Your cart is currently empty!
Testimonial
How 1 Cancer Survivor Triggered Interest in Repurposed Antiparasitic Drugs
Growing numbers of cancer sufferers are trying the Tippens Protocol—a remedy not approved by the FDA—with oncologists reporting good anecdotal success.
Joe Tippens never planned to discover a potential remedy that he credits with saving his life and thrusting him into the spotlight among notable cancer survivors. The 67-year-old businessman told The Epoch Times that he just wanted to beat a type of cancer with an extremely low survival rate.
In August 2016, Tippens was diagnosed with small cell lung cancer with a fist-sized tumor. After undergoing chemotherapy and radiation five times per week in Houston, the large tumor in his left lung was eliminated. However, Tippens said the treatments came closer to killing him than curing him.
When he returned home to Oklahoma after New Year’s, he received devastating news. His oncologist told him that he had zero chance of surviving for more than a few months.
Story continues below advertisement
“In January of 2017, my [positron-emission tomography] scan lit up like a Christmas tree and I had wide metastasis everywhere, including in my neck, bones, pancreas, and liver,” Tippens said.
Finding a Lifeline
Facing a prognosis of three months to live, Tippens heard an intriguing story from a veterinarian he knew: A scientist with terminal cancer had reportedly cured her lab mice and then herself using fenbendazole, an antiparasitic drug.
Joe Tippens, an Oklahoma-based businessman, has helped numerous cancer patients after he was cured partly by taking fenbendazole.
The story was the beginning of what eventually became the “Joe Tippens Protocol.”
Fenbendazole, used for 30 years to treat intestinal parasites in animals, has not received Food and Drug Administration (FDA) approval for human use, meaning that doctors cannot prescribe it for people. However, with a terminal diagnosis and nothing to lose, Tippens decided to try it alongside his conventional treatments.
Tippens found that Panacur, a trade name for fenbendazole, was sold over the counter at outlets that carry veterinary medications.